Literature DB >> 19414124

Optimal timing of radical cystectomy for patients with T1 bladder cancer.

Bernard H Bochner1.   

Abstract

The optimal treatment of lamina propria invasive bladder cancers remains controversial. Assigning strict treatment guidelines is hampered by the heterogeneous clinical behavior of lamina propria invasive bladder cancers. Although many T1 lesions respond very well to transurethral resection and adjuvant intravesical therapy, others demonstrate a high rate of recurrence and progression. While bladder preservation is desired by most patients, experience has documented that survival is compromised in a substantial percentage of patients if T1 disease is allowed to progress. Radical cystectomy for T1 disease is associated with an excellent survival; however, the optimal timing of radical cystectomy remains one of the more difficult clinical dilemmas in the management of patients with bladder cancer. This article reviews the various features associated with an increased risk of disease progression to provide a framework for optimizing the timing of radical cystectomy.

Entities:  

Mesh:

Year:  2009        PMID: 19414124     DOI: 10.1016/j.urolonc.2008.10.022

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  5 in total

1.  Prognostic significance of tumor location in high-grade non-muscle-invasive bladder cancer.

Authors:  Ivana Vukomanovic; Vidosav Colovic; Ivan Soldatovic; Jovan Hadzi-Djokic
Journal:  Med Oncol       Date:  2011-06-09       Impact factor: 3.064

2.  The incidence of prostate cancer and urothelial cancer in the prostate in cystoprostatectomy specimens in a tertiary care Canadian centre.

Authors:  Sri Sivalingam; Darrel Drachenberg
Journal:  Can Urol Assoc J       Date:  2013 Jan-Feb       Impact factor: 1.862

3.  Surveillance and treatment of non-muscle-invasive bladder cancer in the USA.

Authors:  Daniel A Barocas; Denise R Globe; Danielle C Colayco; Ahunna Onyenwenyi; Amanda S Bruno; Thomas J Bramley; Rachel J Spear
Journal:  Adv Urol       Date:  2012-05-10

4.  Myosteatosis as a novel prognostic biomarker after radical cystectomy for bladder cancer.

Authors:  Shimpei Yamashita; Yuya Iwahashi; Haruka Miyai; Takashi Iguchi; Hiroyuki Koike; Satoshi Nishizawa; Nagahide Matsumura; Keizo Hagino; Kazuro Kikkawa; Yasuo Kohjimoto; Isao Hara
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

5.  Usefulness of Preoperative High Systemic Immune-Inflammation Index as a Prognostic Biomarker in Patients Who Undergo Radical Cystectomy for Bladder Cancer: Multicenter Analysis.

Authors:  Shimpei Yamashita; Yuya Iwahashi; Haruka Miyai; Nagahide Matsumura; Keizo Hagino; Kazuro Kikkawa; Yasuo Kohjimoto; Isao Hara
Journal:  Diagnostics (Basel)       Date:  2021-11-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.